Exon-skipping therapies for Duchenne muscular dystrophy, a class of drugs that triggered fierce regulatory debate when they ...

Greenwich LifeSciences (GLSI) stock is a "Buy" as phase 3 FLAMINGO-01 advances in HER2-positive breast cancer with two major ...

Percutaneous coronary intervention successfully alleviated chest pain symptoms in select patients with chronic total occlusion and reduced the frequency of anginal events, a speaker ...

Five abstracts accepted including Late-breaking Science oral and poster presentations of Phase 3 X-TOLE2 study results for azetukalner in focal onset seizuresPoster presentations also include long-ter ...

"It has been suggested that treatment with levothyroxine may be considered in patients aged 65 years or older with ...

While recent FDA guidance speaks to the agency’s support of innovative trial designs—including the use of external ...

The American Society for Clinical Oncology to be held in Chicago May 29 – June 2, 2026BELTSVILLE, Md., March 31, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage ...

Palisade Bio (NASDAQ:PALI) said it generated encouraging safety, pharmacokinetic and early efficacy signals from an open-label Phase 1b study of PALI-2108 in fibrostenotic Crohn’s disease, a difficult ...

The local biotech sector has had a month to forget (hence us reminding you of it here), with most of the sector-leading ...

Early and continuous treatment with acoramidis is linked to lower risks for death and heart-related hospitalization than delayed treatment in patients with transthyretin amyloid cardiomyopathy.

Some researchers believe that girls and women who have high verbal ability and anxiety may be better served by different ...